Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudeep Banerjee

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Surgical Oncology|July 13, 2019
Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient RegistryEmelia Stuart, Sudeep Banerjee, Jorge de la Torre, et al.
Journal of Translational Medicine|August 1, 2019
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxomaSudeep Banerjee, Christopher L Corless, Markku M Miettinen, et al.
Cancer Medicine|February 13, 2023
Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019Anindita Dutta, Tushar Mungle, Nandita Chowdhury, et al.
Cancer Cell International|November 4, 2022
DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohortAnkita Chatterjee, Akash Bararia, Debopriyo Ganguly, et al.
Scientific Reports|June 27, 2022
Transverse oscillating bubble enhanced laser-driven betatron X-ray radiation generationRafal Rakowski, Ping Zhang, Kyle Jensen, et al.
Molecular Cancer Therapeutics|August 11, 2021
KIT<sup>low</sup> Cells Mediate Imatinib Resistance in Gastrointestinal Stromal TumorSudeep Banerjee, Hyunho Yoon, Stephanie Ting, et al.
European Journal of Medical Research|December 14, 2025
Identification of a chromatin-modifying gene-histone lysine N-methyl transferase (KMT2C/MLL3) as a potential immunomodulator oncogene in Indian pancreatic cancer patientsSounetra Choudhury, Akash Bararia, Arunima Maiti, et al.
Hepatology (Baltimore, Md.)|May 2, 2015
A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinomaSudeep Banerjee, David S Wang, Hyun J Kim, et al.
Radiology|September 25, 2015
The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell CarcinomaNeema Jamshidi, Eric Jonasch, Matthew Zapala, et al.
JCO Precision Oncology|July 12, 2021
Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver MutationsEleftherios A Makris, Ashwyn K Sharma, Erik N Bergstrom, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Surgical Oncology|July 13, 2019
Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient RegistryEmelia Stuart, Sudeep Banerjee, Jorge de la Torre, et al.
Journal of Translational Medicine|August 1, 2019
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxomaSudeep Banerjee, Christopher L Corless, Markku M Miettinen, et al.
Cancer Medicine|February 13, 2023
Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019Anindita Dutta, Tushar Mungle, Nandita Chowdhury, et al.
Cancer Cell International|November 4, 2022
DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohortAnkita Chatterjee, Akash Bararia, Debopriyo Ganguly, et al.
Scientific Reports|June 27, 2022
Transverse oscillating bubble enhanced laser-driven betatron X-ray radiation generationRafal Rakowski, Ping Zhang, Kyle Jensen, et al.
Molecular Cancer Therapeutics|August 11, 2021
KIT<sup>low</sup> Cells Mediate Imatinib Resistance in Gastrointestinal Stromal TumorSudeep Banerjee, Hyunho Yoon, Stephanie Ting, et al.
European Journal of Medical Research|December 14, 2025
Identification of a chromatin-modifying gene-histone lysine N-methyl transferase (KMT2C/MLL3) as a potential immunomodulator oncogene in Indian pancreatic cancer patientsSounetra Choudhury, Akash Bararia, Arunima Maiti, et al.
Hepatology (Baltimore, Md.)|May 2, 2015
A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinomaSudeep Banerjee, David S Wang, Hyun J Kim, et al.
Radiology|September 25, 2015
The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell CarcinomaNeema Jamshidi, Eric Jonasch, Matthew Zapala, et al.
JCO Precision Oncology|July 12, 2021
Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver MutationsEleftherios A Makris, Ashwyn K Sharma, Erik N Bergstrom, et al.
Pageof 6